Metallothioneins in human tumors and potential roles in carcinogenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 533, Issue 1-2, 2003, Pages 201-209

  Cherian, M George ^a   Jayasurya, A ^b   Bay, Boon Huat ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Drug resistance; Metallothionein; Nuclear localization

Indexed keywords

ESTROGEN RECEPTOR; ISOPROTEIN; METALLOTHIONEIN; PROTEIN P53; THROMBOPLASTIN;

ADENOCARCINOMA; BLADDER TUMOR; BREAST TUMOR; CANCER CELL; CANCER GRADING; CARCINOGENESIS; CELL TYPE; COLON TUMOR; DOWN REGULATION; EPITHELIUM; GENE MUTATION; GERM CELL TUMOR; HUMAN; IN VITRO STUDY; KIDNEY TUMOR; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG TUMOR; METHYLATION; NASOPHARYNX TUMOR; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROSTATE TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; SALIVARY GLAND TUMOR; TESTIS TUMOR; THYROID TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0345276580     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.07.013     Document Type: Review

References (64)

1. Margoshes M., Vallee B.L. A cadmium protein from equine kidney cortex. J. Am. Chem. Soc. 79:1957;4813-4814.
2. Robbins A.H., Stout C.D. X-ray structure of metallothionein. Methods Enzymol. 205:1991;485-502.
3. Otvos J.D., Armitage I.M. Structure of the metal clusters in rabbit liver metallothionein. Proc. Natl. Acad. Sci. 77:1991;7094-7098.
4. Winge D.R. Limited proteolysis of metallothionein method. Methods Enzymol. 205:1991;438-447.
5. Uchida Y., Takio K., Titani K., Ihara Y., Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 7:1991;337-347.
6. Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelly E.J., Zambrowicz B.P., Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry. 33:1994;7250-7259.
7. West A.K., Stallings R., Hildebrand C.E., Chiu R., Karin M., Richards R.I. Human metallothionein genes: structure of the functional locus at 16q13. Genomics. 8:1990;513-518.
8. Sutherland G.R., Baker E., Callen D.F., Garson O.M., West A.K. The human metallothionein gene cluster is not disrupted in myelomonocytic leukemia. Genomics. 6:1990;144-148.
9. A Stennard F., Holloway A.F., Hamilton J., West A.K. Characterization of six additional human metallothionein genes. Biochim. Biophys. Acta. 1218:1994;357-365.
10. Karin M., Richards R.I. Human metallothionein genes-primary structure of the metallothionein-II gene and a related processed gene. Nature. 299:1982;797-802.
11. Richards R.I., Heguy A., Karin M. Structural and functional analysis of the human metallothionein 1-A gene: differential induction by metal ions and glucocorticords. Cell. 37:1984;263-272.
12. Schmidt C.J., Jubier M.F., Hamer D.H. Structure and expression of two human metallothionein-1 isoform genes and a related pseudogene. J. Biol. Chem. 260:1985;7731-7737.
13. Foster R., Johroudi N., Varshney U., Gedamu L. Structure and expression of the human metallothionein-1G gene. Differential promoter activity of two linked metallothionein-1 genes in response to heavy metals. J. Biol. Chem. 263:1988;11528-11535.
14. Heguy A., West A.K., Richards R.I., Karin M. Structure and tissue specific expression of the human metallothionein 1B gene. Mol. Cell. Biol. 6:1986;2149-2157.
15. Palmiter R.D., Findley S.D., Whitmore T.E., Durnam D.M. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. 89:1992;6333-6337.
16. Kagi J.H.R., Vallee B.L. Metallothionein: a cadmium and zinc containing protein from equine renal cortex. J. Biol. Chem. 235:1960;3460-3465.
17. Nartey N.O., Banerjee D., Cherian M.G. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of fetal human liver and kidney, and its changes during development. Pathology. 19:1987;233-238.
18. Sato M., Brenner I. Oxygen free radicals and metallothionein. Free Rad. Biol. Med. 14:1993;325-327.
19. Apostolova M.D., Cherian M.G. Nuclear localization of metallothionein during cell proliferation and differentiation. Cell. Mol. Biol. (Noisy-le-grand). 46:2000;347-356.
20. Panemangalore M., Banerjee D., Onosaka S., Cherian M.G. Changes in the intracellular accumulation and distribution of metallothionein in rat liver and kidney postnatal development. Dev. Biol. 97:1983;95-102.
21. Chan H.M., Cherian M.G. Oncogenic changes in hepatic metallothionein isoforms in prenatal and newborn rats. Biochem. Cell. Biol. 71:1993;133-140.
22. Cherian M.G., Huang P.C., Klaassen C.D., Liu Y.P., Longfellow D.G., Waalkes M.P. National cancer institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res. 53:1993;922-925.
23. Cherian M.G., Howell S.B., Imura N., Klaassen C.D., Koropatnick J., Lazo J.S., Waalkes M.P. Role of metallothionein in carcinogenesis. Toxicol. Appl. Pharmacol. 126:1994;1-5.
24. Cherian M.G. The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ. Health Perspect. 102:1994;131-135.
25. Nartey N., Cherian M.G., Banerjee D. Immunohistochemical localization of metallothionein in human thyroid tumors. Am. J. Pathol. 129:1987;177-182.
26. Kontozoglou T.E., Banerjee D., Cherian M.G. Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells. Virc. Arch. A: Pathol. Anat. Histopathol. 415:1989;545-549.
27. Chin J.L., Banerjee D., Kadhim S.A., Kontozoglou T.E., Chauvin P.J., Cherian M.G. Metallothionein in testicular germ cell tumors and drug resistance. Cancer. 72:1993;3029-3035.
28. Schmid K.W., Ellis I.O., Gee J.M., Darke B.M., Lees W.E., Kay J., Cryer A., Stark J.M., Hittmair A., Ofner D.M. Presence and possible significance of immunohistochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virc. Arch. A: Pathol. Anat. Histopathol. 422:1993;153-159.
29. Goulding H., Jasani B., Pereira H., Reid A., Galea M., Bell J.A., Elaston C.W., Robertson J.F., Blaney R.W., Nicholson R.A., Schmid K.W. Metallothionein expression in human breast cancer. Br. J. Cancer. 72:1995;968-972.
30. Jin R., Bay B.H., Chow V.T.K., Tan P.H. Metallothionein 1F mRNA expression correlated with histological grade in breast carcinoma. Breast Cancer Res. Treat. 1933:2001;1-8.
31. Chauvin P.J., Cherian M.G., Wysocki G.P., Pringle G.A. A comparison of metallothionein expression in human normal and neoplastic salivary gland tissue using immunohistochemistry. Toxicologist. 12:1992;379.
32. Jin R., Bay B.H., Chow V.T.R., Tan P.H., Dheen S.T. Significance of metallothionein expression in breast myoepithelial cells. Cell Tissue Res. 303:2001;221-226.
33. Bay B.H., Jin R., Jayasurya A. Analysis of metallothionein expression in human cancers. Acta Histochem. Cytochem. 54:2001;171-176.
34. Abdel-Mageed A.B., Agrawal K.C. Antisense down-regulation of metallotheionein induced growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther. 4:1997;199-207.
35. Meskel H., Cherian M.G., Martinez V.J., Veinot L.A., Frei J.V. Metallothionein as an pithelial proliferative compartment marker for DNA flow cytometry. Mod. Pathol. 6:1993;755-760.
36. Dziegiel P., Fongocy J., Sudar E., Surowiak P., Kornafel J., Zebel M. Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinoma of large intestine. Histol. Histopathol. 18:2003;401-407.
37. Ioachim E.E., Goussia A.C., Agnantis N.J., Machera M., Tsiano E.V., Kappas A.M. Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J. Clin. Pathol. 52:1999;876-879.
38. Moussa M., Kloth D., Peers G., Cherian M.G., Frei J.V., Chin J.L. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum levels of prostate specific antigen. Clin. Invest. Med. 20:1997;371-380.
39. Deng D.X., Chakrabarti S., Waalkes M.P., Cherian M.G. Metallothionein and apoptosis in primary human hepatocellular carcinoma and metastatic carcinoma. Histopathology. 32:1998;348-355.
40. Cai L., Wang C.J., Xu Z.L., Deng D.X., Chakrabarti S., Cherian M.G. Metallothionein and apoptosis in primary human hepatocellular carcinoma from northern China. Anticancer Res. 18:1998;4667-4672.
41. Jacob S.T., Majumader S., Ghoshal K. Suppression of metallothionein-I/II expression and its probable molecular mechanisms. Environ. Health Perspect. 110:2002;827-830.
42. Murphy D., McGowan A.T., Crowther D. Metallothionein levels in ovarian tumors before and after chemotherapy. Br. J. Cancer. 63:1991;711-714.
43. Germain I., Tetu B., Frisson J., Mondor M., Cherian M.G. Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. Int. J. Gynecol. Pathol. 15:1996;54-62.
44. Tan Y., Sinnish R., Bay B.H., Singh G. Metallothionein expression and nuclear size in benigh borderline and malignant serous ovarian tumors. J. Pathol. 189:1999;60-65.
45. Jin R., Chow V.T.K., Tan P.H., Dheen S.T., Duan W., Bay B.H. Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis. 23:2002;81-86.
46. Jin R., Bay B.H., Chow V.T.K., Tan P.H., Lin V.C.L. Metallothionein IE mRNA is highly expressed in estrogen receptor-negative human invasive ductal breast cancer. Br. J. Cancer. 83:2000;319-323.
47. Sens M.A., Somji S., Scott H., Garett S.H., Beall C.L., Sens D.A. Metallothionein isoform 3 overexpression is associated with breast cancers have a poor prognosis. Am. J. Pathol. 159:2001;21-26.
48. Nguyen A., Jing Z., Mahoney P.S., Davis R., Sikka S.C., Agrawal K.C., Abdel-Mageed A.B. In vivo gene expression profile analysis of metallothionein in renal cell carcinoma. Cancer Lett. 160:2000;133-140.
49. Holy J.G., Garett S.H., Sens M.A., Todd J.H., Sens D.A. Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures and renal cell carcinoma. Toxicol. Lett. 92:1997;149-160.
50. Sens M.A., Somji S., Lamm D.L., Garett S.H., Slovinsky F., Todd J.H., A Sens D. Metallothionein isoform 3 as a potential biomarker for bladder cancer. Environ. Health Perspect. 108:2000;413-418.
51. Somji S., Sens M.A., Lamm D.L., Garett S.H., Sens D.A. Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-IX mRNA in bladder cancer. Cancer Detect. Prev. 25:2001;65-75.
52. Jayasurya A., Bay B.H., Yap W.M., Tan N.G., Tan B.K.H. Proliferative potential in nasopharyngeal carcinoma: correlation with metallothionein expression and tissue zinc levels. Carcinogenesis. 21:2000;1809-1812.
53. Garett S.H., Sens M.A., Shukla D., Flores L., Somji S., Todd J.H., Sens D.A. Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-IX in advanced prostate cancer. Prostate. 43:2000;125-135.
54. S.K. Tai, O.J.K. Tan, V.T.K. Chow, R. Jin, J.L. Jones, P.H. Tan, A. Jayasurya, B.H. Bay, Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel non-silent MT-1H mutant variant, Am. J. Pathol., 2003, in press.
55. Zeng J., Vallee B.L., Kagi J.H. Zinc transfer from transcription factor IIIA fingers to thionein clusters. Proc. Natl. Acad. Sci. 88:1991;9984-9988.
56. Shimoda R., Achanzar W.E., Qu W., Nagamine T., Takagi H., Mori M., Waalkes M.P. Metallothionein is a potential negative regulator of apoptosis. Toxicol. Sci. 73:2003;294-300.
57. Joseph M.G., Banerjee D., Kocha W., Feld R., Stitt L.W., Cherian M.G. Metallothionein expression in patients with small cell carcinoma of the lung. Correlation with other molecular markers and clinical outcome. Cancer. 92:2001;836-842.
58. Ioachim E., Assimakopoulos D., Peschos D., Zissi A., Skevas A., Aganantis N.J. Immunohistochemical expression of metallothionein in benign premalignant and maligant epithelium of the larynx: correlation with p53 and proliferative cell nucleus antigen. Pathol. Res. Pract. 195:1999;809-814.
59. Ioachim E.E., Charchanti A.V., Stavropoulos N.E., Athanassion E.D., Michael M.C., Agnantis N.J. Localizaiton of metallothionein in urothelial carcinoma of the human urinary bladder: an immunochistochemical study including correlation with HLA-DR antigen, p53 and proliferation induces. Anticancer Res. 21:2001;1757-1761.
60. Meplan C., Richard M.J., Hainaut P. Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelator in vitro and in intact cells. Oncogene. 19:2000;5227-5236.
61. Fan L.Z., Cherian M.G. Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br. J. Cancer. 87:2002;1019-1926.
62. Bakka A., Endresen L., Johnson A.B.S., Edminson P.D., Rugstad H.E. Resistance against cisplatin in cultured cells with high content of metallothionein. Toxicol. Appl. Pharmacol. 61:1981;215-226.
63. Satoh M., Cherian M.G., Imura N., Shimizu H. Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res. 54:1994;5255-5257.
64. Ioachim E.E., Goussia A.C., Agnantis W.J., Machera M., Tsianos E.V., Kappas A.M. Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J. Clin. Pathol. 52:1999;876-879.